GLP-1 encourages your body to release more insulin, preventing spikes
The key is quality and consistency
Either way, the decision should be guided by your body and your provider, not guesswork
However, these molecular mechanisms need to be further elucidated ( 2 The AMPK pathway AMPK is a serine/threonine kinase comprised of a catalytic alpha subunit and two subunits of beta and gamma regulators ( 3 The relationship between AMPK and antidiabetic drugs Metformin, the most widely used oral agent for the treatment of T2D, is historically known as an AMPK activator ( 3.1 SGLT2i and AMPK The SGLT2i (Sodium-glucose co-transport 2 inhibitors) are a class of antidiabetic agents, targeting the major glucose transporter SGLT2 in the kidney
[DOI] [PMC free article] [PubMed] [Google Scholar] 32.Sarwar H., Rafiqi S.I., Ahmad S., Jinna S., Khan S.A., Karim T., Qureshi O., Zahid Z.A., Elhai J.D., Levine J.C., et al